Vontier Reports Third Quarter Results and Revises Full-Year 2022 Outlook
Go back to Vontier Reports Third Quarter Results and Revises Full-Year 2022 Outlook| Savient Pharmaceuticals, Inc. (NYSE: VNT) | Delayed: 31.24 -0.12 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.36 | 52 Week High | $9.92 | |||
| Open | $31.60 | 52 Week Low | $9.10 | |||
| Day High | $31.74 | P/E | N/A | |||
| Day Low | $30.92 | EPS | $-0.94 | |||
| Volume | 1,241,807 | |||||
